Critical evaluation of the methodology used by Wilson-Davies et al., (2020) entitled “Concerning the Optigene Direct LAMP assay, and it`s use in at-risk groups and hospital staff” - 17/02/21

Dr Veronica Fowler ^{a, ⁎} , Dr Angela Douglas ^a, Professor Keith Godfrey ^b, Professor Anthony Williams ^c, Professor Andrew Beggs ^d, Stephen Kidd ^{a, e}, Dr Nick Cortes ^{e, g}, Professor Mark Wilcox ^f, Dr Kerrie Davies ^f, Melanie Smith ^{a, h}, Professor Dame Sue Hill ^a

^a DHSC and NHS Test and Trace, United Kingdom 

^b MRC Lifecourse Epidemiology Unit and NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, United Kingdom 

^c Faculty of Medicine, University of Southampton, United Kingdom 

^d Institute of Cancer & Genomic Science, University of Birmingham, United Kingdom 

^e Microbiology Department, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, United Kingdom 

^f University of Leeds and Leeds Teaching Hospitals NHS Trust, United Kingdom 

^g St Bernard's Hospital, Gibraltar Health Authority, Gibraltar, United Kingdom 

^h National Infection Service, Public Health England, United Kingdom 

^⁎Corresponding author.

Le texte complet de cet article est disponible en PDF.